Novanta Buys Riverpoint Medical for Up to $1.45B to Boost Minimally Invasive Surgery Portfolio

Novanta to buy Riverpoint Medical for up to $1.45B, doubling its recurring medical consumables revenue and expanding into minimally invasive surgical devices. Deal expected to close Q3 2026.